Anjali Vaidya, MD, FACC, FASE, FACP, who serves as Co-Director of the Pulmonary Hypertension, Right Heart Failure & Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at Temple University Hospital, shared her insights with Healio regarding a recent study. The findings were presented at the 2025 International Society for Heart and Lung Transplantation Annual Meeting. The study revealed that among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%.
New study shows 60% survival rate in pulmonary arterial hypertension patients
0Comments
Related
Phillies place Jhoan Duran on injured list with mild oblique strain
Philadelphia Phillies closer Jhoan Duran was placed on the injured list with a mild oblique strain. Manager Rob Thomson expects Brad Keller will take over save opportunities during Duran’s absence. The team awaits further updates regarding Duran’s return.
Phillies prospect Luke Gabrysh strikes out four batters in one inning for Jersey Shore
Phillies prospect Luke Gabrysh struck out four batters in one inning during a game for High-A Jersey Shore. His performance included nine total strikeouts over four no-hit innings.
Andrew Painter impresses in early MLB starts despite challenges
Philadelphia Phillies pitcher Andrew Painter impressed coaches by performing well despite illness before his recent start against Arizona. His commitment extends beyond pitching as he learns from teammates during games at Citizens Bank Park.